On this page

What is teplizumab (Tzield)?

Teplizumab (brand name Tzield) is a medication that can delay the onset of type 1 diabetes in people at high risk of developing the condition.

How does teplizumab work?

In type 1 diabetes, the immune system mistakenly attacks insulin-producing cells in the pancreas called beta cells. This reduces insulin production over time, causing blood sugar levels to rise. Eventually, the patient must take supplemental insulin for life.

Teplizumab works by modifying immune cells called T cells, which slows the destruction of beta cells. This allows the pancreas to continue making insulin longer, delaying the need for insulin therapy. One study showed that teplizumab postponed the need for supplemental insulin by two years on average.


Who Is eligible for teplizumab?

The Food and Drug Administration (FDA) has approved teplizumab for patients age 8 and older who are at high risk of developing type 1 diabetes. To be considered high risk, you must meet the following criteria:

  • Have at least two autoantibodies (antibodies that attack normal substances made by the body)
  • Show elevated blood sugar levels, such as an A1C test result in the prediabetic range or an abnormal result on an oral glucose tolerance test
  • Not yet require insulin therapy

These are the features of stage 2 diabetes. Stage 2 typically progresses to stage 3, when symptoms appear and supplemental insulin is needed.

Teplizumab is not approved for patients already diagnosed with type 1 diabetes.

What should I expect from teplizumab treatment?

First, you will be screened to determine whether you are eligible based on your autoantibodies and blood sugar levels. You'll have additional blood tests to check that your liver and kidneys are working normally and that you don't have any signs of an infectious disease.

If no safety concerns are found, you will receive teplizumab as a daily intravenous (IV) infusion for 14 consecutive days. These treatments take place in an outpatient infusion center and typically take two to three hours each.

Awards & recognition

Recognized nationally for excellence, we pair world-class medical expertise with compassionate care to deliver the best possible outcomes for patients.
  • Among the nation’s best in 13 specialties

  • One of the nation’s best for diabetes care & endocrinology

  • Rated high-performing hospital for diabetes care

Related services & conditions

  • Specialties
  • Conditions
    • Type 1 Diabetes
    • Pediatric Pre-Diabetes
  • Treatments
    • Diabetes Therapy

UCSF Health medical specialists have reviewed this information. It is for educational purposes only and is not intended to replace the advice of your doctor or other health care provider. We encourage you to discuss any questions or concerns you may have with your provider.